Search News
| 8.49 Delayed Data As of 12:01pm ET |  +0.36 / +4.43%Today’s Change | 6.85 Today|||52-Week Range 12.87 | -24.20% Year-to-Date |
| Previous close | 8.13 |
| Today’s open | 8.25 |
| Day’s range | 8.11 - 8.49 |
| Volume | 18,298 |
| Average volume (3 months) | 18,959 |
| Market cap | $112.6M |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -52.50% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 5.1 |
| Price/Sales | 41.94 |
| Price/Book | 1.42 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVIVInVivo Therapeutics ... | -0.06 | -2.66% |
| CLBSCaladrius Bioscience... | +0.06 | +1.10% |
| MTEMMolecular Templates ... | +0.15 | +3.00% |
| CSBRChampions Oncology I... | +0.04 | +0.46% |
| Next reporting date | July 31, 2018 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $1.7M |
| Annual profit (last year) | -$7.8M |
| Net profit margin | -449.62% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman & Chief Executive Officer Mitchell H. Gold |
President & Director Jay Venkatesan |
Corporate headquarters Seattle, Washington |
